Literature DB >> 5322058

The use of ethacrynic acid in patients with cirrhosis and ascites.

F L Lieberman, T B Reynolds.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5322058

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  [The effectivness of ethacrynic acid, amiloride HCl and aldadiene K in kidney insufficiency].

Authors:  E Quellhorst; F Scheler
Journal:  Klin Wochenschr       Date:  1970-04-15

Review 2.  Pharmacotherapy of ascites associated with cirrhosis.

Authors:  P Ginès; V Arrovo; J Rodés
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

3.  Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.

Authors:  F L Lieberman; S Ito; T B Reynolds
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

4.  Spironolactone diuresis in patients with cirrhosis and ascites.

Authors:  R C Eggert
Journal:  Br Med J       Date:  1970-11-14

5.  Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.

Authors:  V Arroyo; J Bosch; R Casamitjana; J Cabrera; F Rivera; J Rodés
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

6.  Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Amine Benmassaoud; Suzanne C Freeman; Davide Roccarina; Maria Corina Plaz Torres; Alex J Sutton; Nicola J Cooper; Laura Iogna Prat; Maxine Cowlin; Elisabeth Jane Milne; Neil Hawkins; Brian R Davidson; Chavdar S Pavlov; Douglas Thorburn; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.